2016
DOI: 10.1021/acs.molpharmaceut.6b00716
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Lipid-Based Hexosomes as Versatile Vaccine Carriers

Abstract: Subunit vaccines typically show insufficient immunogenicity. To address this issue, we developed a novel self-adjuvanting particulate carrier system based upon the lipids phytantriol (Phy) and mannide monooleate (MaMo). Phy is a lipid known to form nonlamellar phases in fully hydrated systems, whereas MaMo has been found to promote immune responses in emulsion form. A bulk phase composition of Phy/MaMo (14 wt %) showed hexagonal (HII) phase behavior over a practical temperature range (including room and body t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
18
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(19 citation statements)
references
References 42 publications
0
18
0
Order By: Relevance
“…In the presence of a proper stabilizer [ 6 ], liquid crystal phases can be arranged in different supramolecular structures such as cubosomes [ 7 , 8 ] or hexosomes [ 9 , 10 , 11 ], which could potentially be used for intravenous injection. This is because of their scarce viscosity as well as their ability to maintain the internal nanostructure of the bulk systems and keep it intact.…”
Section: Introductionmentioning
confidence: 99%
“…In the presence of a proper stabilizer [ 6 ], liquid crystal phases can be arranged in different supramolecular structures such as cubosomes [ 7 , 8 ] or hexosomes [ 9 , 10 , 11 ], which could potentially be used for intravenous injection. This is because of their scarce viscosity as well as their ability to maintain the internal nanostructure of the bulk systems and keep it intact.…”
Section: Introductionmentioning
confidence: 99%
“…21 − 57 Among the nanostructured carriers, the liquid crystalline lipid assemblies have shown considerable potential in protecting instable encapsulated molecules from degradation and enhancing their bioavailability and diffusion through the biological barriers. 2 , 15 , 24 , 36 , 43 , 47 50 …”
Section: Introductionmentioning
confidence: 99%
“…Such carrier particles (cubosomes, hexosomes, or spongosomes) do not rapidly break upon contact with biological fluids after administration and may provide sustained release. 3 , 6 , 24 , 43 , 44 , 49 Moreover, they can be sterically stabilized by hydrophilic shells to avoid eventual aggregation in the milieu. 3 , 10 , 14 , 29 , 47 , 48 …”
Section: Introductionmentioning
confidence: 99%
“…In excess of water, LLC can be dispersed into sub-micron sized colloidal particles, maintaining the internal nanostructure of the bulk system [ 16 , 17 , 18 , 19 ]. Thus, thermodynamically stable colloidal dispersions of the inverse bicontinuous cubic phases or hexagonal phases, named cubosomes or hexosomes, respectively, can be also produced, making appealing drug delivery systems [ 14 , 20 , 21 , 22 , 23 ]. The colloidal stability of these LLC particles, also known as ISAsomes (Internally Self-Assembled particles), is achieved by the action of stabilizing polymers [ 17 ].…”
Section: Introductionmentioning
confidence: 99%